The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
FAIRLANE: A phase II randomized, double-blind, study of the Akt inhibitor ipatasertib (Ipat, GDC-0068) in combination with paclitaxel (Pac) as neoadjuvant treatment for early stage triple-negative breast cancer (TNBC).
 
Mafalda Oliveira
No Relationships to Disclose
 
Cristina Saura
No Relationships to Disclose
 
Antonio Gonzalez-Martin
No Relationships to Disclose
 
Jay C. Andersen
No Relationships to Disclose
 
Julie Gottlieb Fisher
No Relationships to Disclose
 
Isabel Calvo
No Relationships to Disclose
 
Eva Ciruelos
No Relationships to Disclose
 
Miquel Gil
No Relationships to Disclose
 
Lorena De La Pena
No Relationships to Disclose
 
Marta Llobet-Canela
No Relationships to Disclose
 
YounJeong Choi
Employment - Genentech
Stock and Other Ownership Interests - Roche/Genentech
 
Shidong Jia
Employment - Genentech
Stock and Other Ownership Interests - Roche/Genentech
 
Sreenivasu Yalamanchili
Employment - Genentech
Stock and Other Ownership Interests - Roche/Genentech
 
Stina Mui Singel
Employment - Genentech
Stock and Other Ownership Interests - Roche/Genentech
 
Premal H. Patel
Employment - Genentech
Stock and Other Ownership Interests - Roche Pharma AG
 
Jose Baselga
No Relationships to Disclose
 
Steven J. Isakoff
Consulting or Advisory Role - BIND Biosciences; Myriad Genetics
Research Funding - Abbvie; Genentech; PharmaMar
Travel, Accommodations, Expenses - Genentech; Myriad Genetics; Myriad Genetics